{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Potential Antiviral Treatment for COVID-19: Remdesivir

Activity Steps

Purpose of Activity

To provide a comprehensive update on the use of remdesivir to treat patients who have COVID-19.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Explain the indications, actions, interactions, and evidence pertaining to the use of remdesivir to treat COVID-19.
  2. Summarize the recommendations for the administration of remdesivir to patients who have COVID-19.
Price: $12.95

Credits:

  • ANCC 1.0 CH / 1.0 APH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: CNS1120
Published: Nov/Dec 2020
Expires: 12/2/2022
Required Passing Score: 7/10 (70%)
Authors: Patricia Anne O?Malley, PhD, APRN-CNS